[1]
K. Aksentiychuk, N. Kurlyak, and E. Sklyarov, “Monitoring of liver function in patients with fatty liver disease in combination with coronary heart disease and type 2 diabetes”, Curr. Issues Pharm. Med. Sci., vol. 26, no. 4, pp. 376–378, Dec. 2013, doi: 10.12923/j.2084-980X/26.4/a.04.